Patent ID: 11969435
Assignee: CORCEPT THERAPEUTICS INCORPORATED
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of treating hyperglycemia secondary to hypercortisolism in a patient with Cushing's syndrome, said patient taking an original once-daily (OD) oral dose of 1200 milligrams per day (mg/day) of mifepristone, comprising reducing said original OD oral mifepristone dose of 1200 mg/day to an adjusted OD oral mifepristone dose of 900 mg/day wherein the patient is receiving concomitant administration of a strong CYP3A inhibitor selected from the group consisting of ketoconazole, itraconazole, nefazodone, ritonavir, nelfinavir, indinavir, boceprevir, clarithromycin, conivaptan, lopinavir, posaconazole, saquinavir, telaprevir, cobicistat, troleandomycin, tipranavir, paritaprevir and voriconazole.